Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000314584 | SCV001809927 | uncertain significance | Glanzmann thrombasthenia | 2024-04-16 | reviewed by expert panel | curation | The intronic variant NM_000419.5(ITGA2B):c.574+10A>G has not been reported in the literature. It has previously been submitted to ClinVar (SCV000403390.2 and SCV001006746.1) however the affected status of the individuals is not reported. The highest population minor allele frequency in gnomAD v4.0.0 is 0.00003843 (2/52046alleles) in the Admixed American population, which is lower than the ClinGen PD VCEP threshold (<0.0001; PM2_Supporting). It is not predicted to have an impact on splicing (BP7). In summary, there is insufficient evidence at this time to classify the c.574+10A>G variant. GT-specific criteria applied: PM2_supporting, BP7. |
Illumina Laboratory Services, |
RCV000314584 | SCV000403390 | uncertain significance | Glanzmann thrombasthenia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000865732 | SCV001006746 | likely benign | not provided | 2018-07-06 | criteria provided, single submitter | clinical testing |